| 000 | 01469 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250518055613.0 | ||
| 264 | 0 | _c20191231 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1539-0667 | ||
| 024 | 7 |
_a10.1097/NAN.0000000000000341 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalcanes, George | |
| 245 | 0 | 0 |
_aSafety Profile of HTX-019 Administered as an Intravenous Infusion in Patients With Cancer: A Retrospective Analysis. _h[electronic resource] |
| 260 |
_bJournal of infusion nursing : the official publication of the Infusion Nurses Society _c |
||
| 300 |
_a260-263 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiemetics _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAprepitant _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aNeurokinin-1 Receptor Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aVacirca, Jeffrey L | |
| 773 | 0 |
_tJournal of infusion nursing : the official publication of the Infusion Nurses Society _gvol. 42 _gno. 5 _gp. 260-263 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/NAN.0000000000000341 _zAvailable from publisher's website |
| 999 |
_c30056798 _d30056798 |
||